1. Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization
    Julia Schueler et al, 2019, Cells CrossRef
  2. Emerging Roles of Ephexins in Physiology and Disease
    Kwanhyeong Kim et al, 2019, Cells CrossRef
  3. Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomics
    Xue Geng et al, 2023, Medicine CrossRef
  4. The Rho guanine nucleotide exchange factor ARHGEF5 promotes tumor malignancy via epithelial–mesenchymal transition
    Y Komiya et al, 2016, Oncogenesis CrossRef
  5. Rho Guanine Nucleotide Exchange Factor 5 Increases Lung Cancer Cell Tumorigenesis via MMP-2 and Cyclin D1 Upregulation
    Ping He et al, 2015, Molecular Cancer Therapeutics CrossRef
  6. Bioinformatics Analysis of Microarray Datasets to Identify Prognostic Factors in Lung Adenocarcinoma
    Xiang Jin et al, 2020, DNA and Cell Biology CrossRef
  7. Ephexin3/ARHGEF5 Together with Cell Migration Signaling Partners within the Tumor Microenvironment Define Prognostic Transcriptional Signatures in Multiple Cancer Types
    Dante Gustavo Juan-Guadarrama et al, 2023, International Journal of Molecular Sciences CrossRef
  8. The E3 ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression by directly targeting Src protein
    Lihui Zhu et al, 2020, Cell Death & Differentiation CrossRef
  9. The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC)
    Ping-Chih Hsu et al, 2020, Cancers CrossRef